Human chorionic gonadotropin administration does not increase plasma androgen levels in patients undergoing controlled ovarian hyperstimulation.

@article{Fanchin2000HumanCG,
  title={Human chorionic gonadotropin administration does not increase plasma androgen levels in patients undergoing controlled ovarian hyperstimulation.},
  author={R{\'e}nato Fanchin and Dominique de Ziegler and Jo{\"e}lle Taieb and François Olivennes and V. Daniel Castracane and Ren{\'e} Frydman},
  journal={Fertility and sterility},
  year={2000},
  volume={73 2},
  pages={
          275-9
        }
}
Serum androgen levels in patients undergoing controlled ovarian hyperstimulation for in vitro fertilization cycles
TLDR
In patients undergoing COH for IVF, androgen levels increase in response to gonadotropin, and then again after hCG administration, although the E2/testosterone ratio correlates with the number of oocytes retrieved, androgens levels do not.
Ovarian androgens but not estrogens correlate with the degree of systemic inflammation observed during controlled ovarian hyperstimulation
TLDR
In patients undergoing COH for IVF, ovarian androgen levels increase in correlation with the degree of inflammation, as reflected by CRP levels, and it is necessary to elucidate whether androgens play a role in or are predictive of the systemic inflammatory response in COH.
Dynamics of serum anti-Müllerian hormone levels during the luteal phase of controlled ovarian hyperstimulation.
TLDR
Although the mechanisms implicated in the mid-luteal AMH increase are unclear, its positive association with small follicle count, but not with luteal progesterone and E2 levels, supports the hypothesis that AMH levels might reflect luteAL follicle development.
Clinical review: The rationale for banning human chorionic gonadotropin and estrogen blockers in sport.
  • David Handelsman
  • Biology, Medicine
    The Journal of clinical endocrinology and metabolism
  • 2006
TLDR
Blood testosterone concentration is a reasonable surrogate measure for muscle growth and increased strength in men undergoing potential stimulation of endogenous blood testosterone concentrations, and prohibition of hCG and estrogen blockers should be restricted to men in which they are well justified.
Short Term Alterations of Hormone Profile Following Oocyte Pick-Up in Women with Polycystic Ovarian Syndrome to Assess the Effect of Multiple Needle Entries Into the Ovarian Cortex and Stroma
TLDR
Comparisons revealed significantly decreased HOMA-IR and serum total testosterone concentrations after intervention and correlation analyses showed significant correlations between number of needle entries, change in HOMa-IR, baseline total testosterone level and change in AMH level.
The use of metformin for women with PCOS undergoing IVF treatment.
TLDR
Short-term co-treatment with metformin for patients with PCOS undergoing IVF/ICSI cycles does not improve the response to stimulation but significantly improves the pregnancy outcome and reduces the risk of OHSS.
The use of metformin in patients with polycystic ovary syndrome undergoing in vitro fertilization
TLDR
While metformin does not improve the outcome of in vitro fertilization in patients with PCOS, its use in patientsWith PCOS undergoing in vivo fertilization significantly reduces the risk of OHSS Grade I.
...
...

References

SHOWING 1-10 OF 17 REFERENCES
Effects of luteal estradiol on the secretory transformation of human endometrium and plasma gonadotropins.
TLDR
In women deprived of ovarian function, administration of P only after 14 days of E2 priming prevented uterine bleeding and induced normal secretory transformations of the endometrium, but failed to suppress plasma gonadotropins.
Clinical-pharmacological studies on human menopausal gonadotrophin.
TLDR
It is concluded that the pharmacokinetic and pharmacodynamic properties of the preparations studied are similar, if not identical, and that there are marked individual differences in patient responsiveness, which are unrelated to the preparation administered.
...
...